
ONPPF
Healthcare · Biotechnology · $56.0M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 7, 2024 | Before the open | — | -0.03 | — |
| Aug 14, 2024 | Before the open | — | -0.03 | — |
| May 30, 2024 | Before the open | — | -0.05 | — |
| Feb 27, 2024 | Before the open | — | -0.06 | — |
| Feb 16, 2023 | Time not confirmed | — | -0.09 | — |
| Nov 8, 2022 | After the close | -0.72 | -1.00 | -38.9% |
| Aug 10, 2022 | After the close | -0.87 | -0.79 | +9.2% |
| May 3, 2022 | After the close | -2.15 | -1.31 | +39.1% |
| Feb 16, 2022 | After the close | -3.10 | -5.23 | -68.7% |
| Nov 23, 2021 | After the close | -4.49 | -10.33 | -130.1% |
| Aug 18, 2021 | After the close | -4.85 | -0.32 | +93.4% |
| May 25, 2021 | After the close | -6.62 | -3.45 | +47.9% |
| Feb 17, 2021 | After the close | -6.22 | -7.59 | -22.0% |
Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally. Its lead product candidate is Pepaxti (melflufen), a drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. The company also engages in the research for small…
| Nov 18, 2020 | After the close | -6.06 | -5.71 | +5.8% |
| Aug 25, 2020 | After the close | -5.26 | -6.79 | -29.1% |
| May 25, 2020 | After the close | -4.17 | -5.37 | -28.8% |
| Feb 19, 2020 | After the close | -3.61 | -4.42 | -22.4% |
| Nov 18, 2019 | After the close | -3.02 | -3.53 | -16.9% |
| Aug 27, 2019 | After the close | -2.60 | -3.52 | -35.4% |
| May 20, 2019 | After the close | 0.00 | -0.38 | — |
| Feb 21, 2019 | After the close | -2.20 | -2.53 | -15.0% |
| Oct 26, 2018 | Time not confirmed | 0.00 | -0.29 | — |
| Jul 12, 2018 | After the close | -1.90 | -3.27 | -72.1% |
| May 16, 2018 | After the close | 0.00 | -0.37 | — |
| Feb 21, 2018 | After the close | 0.00 | -0.18 | — |